Effectiveness of nasal CPAP (Continous Positive Airway Pressure);Wirksamkeit der nasalen CPAP-behandlung (Continuous Positive Airway Pressure)

Therapeutische Umschau

Volumn 57, Issue 7, 2000, Pages 444-448

  Gugger, M ^a   Bassetti, C ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; HYPERTENSION; METHODOLOGY; POSITIVE END EXPIRATORY PRESSURE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SLEEP APNEA SYNDROME; SOMNOLENCE; TRAFFIC ACCIDENT; TREATMENT OUTCOME;

ACCIDENTS, TRAFFIC; CEREBROVASCULAR ACCIDENT; DISORDERS OF EXCESSIVE SOMNOLENCE; HUMANS; HYPERTENSION; POSITIVE-PRESSURE RESPIRATION; RANDOMIZED CONTROLLED TRIALS; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 0034222751     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.57.7.444     Document Type: Article

References (24)

1. Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnea by CPAP applied through the nares. Lancet 1981; 1: 826-65.
2. Wright J, Johns R, Watt I, Melville A, Sheldon T. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airway pressure: a systematic review of the research evidence. BMJ 1997; 314: 851-60.
3. Gugger M, Bassetti C. Gegendarstellung: Evidence-based medicine: Obstruktive Schlafapnoe, CPAP-Behandlung unf Gesundheitsschäden. PRAXIS 1998; 87: 603-4.
4. Australian Health Technology Advisory Committe. The effectiveness and cost effectiveness of nasal continuous positive airway pressure in the treatment of obstructive sleep apnoea in adults. Canberra: Government Public Services 1996.
5. Correspondence. Obstructive sleep apnoea. Lancet 1999; 354: 1212-14.
6. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of continuous positive airway pressure treatment on day-time function in sleep apnoea/hypopnoea syndrome. Lancet 1994; 343: 572-5.
7. Engleman HM, Martin SE, Kingshott RN, Mackay TW, Deary IJ, Douglas NJ. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnea syndrome. Thorax 1998; 53: 341-45.
8. Engleman HM, Kingshott RN, Wraith PK, Mackay TW, Deary IJ, Douglas NJ. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild slep apnea/Hypopnea syndrome. Am J Respir Crit Care Med 1999; 159: 461-67.
9. Jenkins C, Davies RJO, Mullins R, Stradling JR. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 1999; 353: 2100-05.
10. Redline S, Adams N, Strauss ME, Roebuck T, Winters M, Rosenberg C. Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy. Am J Respir Crit Care Med 1998: 157: 858-65.
11. Chervin RD, Guilleminault C. Assessement of sleepiness in clinical practice. Nature Medicine 1995; 1: 1252-53.
12. Poceta JS, Timms RM, Jeong DU et al. Maintenance of wakefulness test in obstructive sleep apnea syndrome. Chest 1992; 101: 893-97.
13. Sangal RB, Thomas L, Mitler MM. Disorders of excessive daytime sleepiness: treatment improves ability to stay awake but does not reduce sleepiness. Chest 1989; 102: 699-703.
14. Engleman H, Joffe D. Neuropsychological function in obstructive sleep apnoea. Review article. Sleep Medicine Reviews 1999; 3: 59-78.
15. Horstmann S, Hess CW, Bassetti C, Gugger M, Mathis J. Sleepiness related accidents in sleep apnea patients. Sleep 2000; im Druck.
16. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000; 320: 479-482.
17. Young T, Peppard P, Palta M et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997; 157: 1746-52.
18. Brooks D, Homer RL, Kozar LF, Render-Texeira CL, Phillipson EA. Obstructive sleep apnea as a cause of systemic hypertension: evidence from a canine model. J Clin Invest 1997; 99: 106-09.
19. Engleman HM, Cough K, Martin SE, Kingshott RN, Padfield PL, Douglas NJ. Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnoea/hypopnoea syndrome: effect in non-dippers. Sleep 1996; 19: 378-81.
20. Calverly PMA. Blood pressure, breathing, and the carotid body. Lancet 1999; 354: 969.
21. Akashiba T, Minemura H, Yamamoto H, Kosaka N, Saito O, Hone T. Nasal CPAP changes blood pressure «non-dippers» to «dippers» in patients with obstructive sleep apnea.
22. Faccenda JF, Boon NA, Douglas NJ. Randomised trial of CPAP on blood pressure in SAHS. Am J Resipr Crit Care Med 1999; 159A: A527.
23. Bassetti C, Aldrich MS. Sleep apnea in acute cerebrovascular disease. Final report on 128 patients. Sleep 1999; 22: 217-23.
24. Hoy CJ, Venelle M, Kingshott RN, Engleman H, Douglas NJ. Can intensive support improve CPAP use in patients with the sleep apnoea/hypopnea syndrome. Am J Respir Crit Care Med 1999; 159: 1096-1100.